Direct gene transfer of NGF into diabetic rat hearts improved cardiac sensory innervation (Ieda et al., 2006) and recombinant NGF has been shown to be safe when administered to diabetic patients with polyneuropathy (Apfel et al., 2000). This evidence concerns the gene NGF and polyneuropathy.